KOPRAN
|
The Current P/S Ratio of KOPRAN is 2.45.
Share Price | ₹324.3 | Sep 19,2024 |
Market Cap | ₹1,562.9 Cr | |
Sales-TTM | ₹637.0 Cr | TTM-Consolidated Results |
Price/Sales | 2.45x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of KOPRAN
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,562.9 Cr] as on Sep 19,2024
(/) Sales [ ₹637.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.45x ]
Thus, for KOPRAN , the investors are currently willing to pay '2.45 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of KOPRAN !
The chart below summarizes the trend in P/S Ratio of KOPRAN over the last five years.
Historical PS (Price/Sales) ratio chart of KOPRAN
PS Ratio Performance Analysis for KOPRAN
- KOPRAN 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.41x.
- KOPRAN 's operated at median p/e ratio of 0.97x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KOPRAN 's p/e ratio peaked in Mar2022 at 2.84x.
- KOPRAN 's p/e ratio hit its five-year low in Mar2020 of 0.3x.
How does KOPRAN 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
KOPRAN | 637.0 | 2.45 | 1,562.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 49,208.8 | 9.00 | 443,025.0 |
CIPLA LTD | 26,139.1 | 5.06 | 132,316.0 |
DR REDDYS LABORATORIES LTD | 28,949.3 | 3.75 | 108,579.0 |
ZYDUS LIFESCIENCES LTD | 20,615.3 | 5.15 | 106,092.0 |
DIVIS LABORATORIES LTD | 8,185.0 | 17.63 | 144,299.0 |
MANKIND PHARMA LTD | 10,649.6 | 9.15 | 97,396.6 |
TORRENT PHARMACEUTICALS LTD | 10,996.0 | 10.31 | 113,401.0 |
LUPIN LTD | 20,797.1 | 4.76 | 98,990.9 |
AUROBINDO PHARMA LTD | 29,718.4 | 2.98 | 88,708.7 |
ABBOTT INDIA LTD | 5,927.5 | 10.02 | 59,419.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs KOPRAN 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.45x |
Max industry PS | 17.63x |
Median industry PS | 5.15x |
Average industry PS | 7.30x |
You may also like the below Video Courses